IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q4 2016 Holdings

Filed 2017-02-13 | 9 holdings | $40.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals Inc(AGIO)COM00847X104$40.3M965,36999.3%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$125.6K12,682,8760.3%
Syros Pharmaceuticals IncCOM87184Q107$58.4K4,806,6560.1%
Editas Medicine Inc(EDIT)COM28106W103$56.1K3,455,3160.1%
Selecta Biosciences Inc(SELBUSD)COM816212104$14.2K826,8620.0%
T2 Biosystems IncCOM89853L104$10.3K1,950,5830.0%
Eleven Biotherapeutics IncCOM286221106$2.5K1,324,0180.0%